Free release
Sodium ((2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl d

Sodium ((2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl d

CAS No. :34393-59-4MDL No. :MFCD00065201Formula :C9H12N3Na3O11P2Boiling Point :-Linear Structure Formula :-InChI Key :JE

Sales:Service@apichina.com
CAS No. :34393-59-4 Brand :Qitai
Formula :C9H12N3Na3O11P2 M.W :469.12

Introduction

CAS No. :34393-59-4 MDL No. :MFCD00065201
Formula : C9H12N3Na3O11P2 Boiling Point : -
Linear Structure Formula :- InChI Key :JENUKVZGXGULDX-LLWADOMFSA-K
M.W : 469.12 Pubchem ID :23519589
Synonyms :
CDP
Chemical Name :Sodium ((2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl diphosphate

Physicochemical Properties

Num. heavy atoms : 28
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.56
Num. rotatable bonds : 6
Num. H-bond acceptors : 12.0
Num. H-bond donors : 3.0
Molar Refractivity : 73.07
TPSA : 252.0 Ų

Pharmacokinetics

GI absorption : Low
BBB permeant : No
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -12.37 cm/s

Lipophilicity

Log Po/w (iLOGP) : -40.62
Log Po/w (XLOGP3) : -4.52
Log Po/w (WLOGP) : -1.33
Log Po/w (MLOGP) : -3.77
Log Po/w (SILICOS-IT) : -4.44
Consensus Log Po/w : -10.94

Druglikeness

Lipinski : 1.0
Ghose : None
Veber : 1.0
Egan : 1.0
Muegge : 3.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : 0.34
Solubility : 1020.0 mg/ml ; 2.17 mol/l
Class : Highly soluble
Log S (Ali) : -0.15
Solubility : 330.0 mg/ml ; 0.703 mol/l
Class : Very soluble
Log S (SILICOS-IT) : 2.73
Solubility : 252000.0 mg/ml ; 537.0 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 4.61
Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram: